JSM 2011 Online Program
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Activity Details
|
|||
414 * | Tue, 8/2/2011, 2:00 PM - 3:50 PM | CC-C224 | |
Bayesian Analysis in Clinical Trials — Contributed Papers | |||
Biopharmaceutical Section , Section on Bayesian Statistical Science | |||
Chair(s): MaryAnn Morgan-Cox, Eli Lilly and Company | |||
2:05 PM | Analysis of Drug Effect on Counts of Lymphocyte Subsets — Jiacheng Yuan, Astellas Pharma Global Development, Inc. | ||
2:20 PM | An Approach to Bayesian Sample Sizing — Robb Muirhead, Statistical Consulting ; Adina Soaita, Pfizer Inc. | ||
2:35 PM | Using Bayesian Method to Predict Responders Based on Clinical Scores in the Initial Weeks of Treatment in a Phase II Multiple Sclerosis Trial — Dazhe Wang, sanofi-aventis ; Lynn Wei, sanofi-aventis | ||
2:50 PM | A Dose-Finding Design for Combination Therapy with Bayesian Bivariate Ordinal Probit Model — Rui Qin, Mayo Clinic ; Jianchang Lin, Florida State University ; Sumithra J. Mandrekar, Mayo Clinic ; Daniel J. Sargent, Mayo Clinic | ||
3:05 PM | A Risk Assessment Framework for Decisionmaking in Drug Product Development — Amit Phansalkar, Straight Line Performance Solutions | ||
3:20 PM | A Transparent and Efficient Approach in Proof-of-Concept Study Design and Subsequent Decisionmaking — Gang Jia, Merck & Co., Inc. ; Paul Delucca, Merck & Co., Inc. ; Bruce Binkowitz, Merck & Co., Inc. ; Daniel Bloomfield, Merck & Co., Inc. | ||
3:45 PM | Floor Discussion |
2011 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.